☆ 4.7 Article

Selenium modulates AR/IGF-1R/EGFR and TROP2 signaling pathways and improves anticancer efficacy in murine mammary carcinoma 4T1

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer

Shuohui Dong et al.

Summary: This study describes the abnormality of glucose metabolism in 5-FU-resistant CRC, and shows that enhanced glycolysis and pentose phosphate pathway are associated with increased HIF-1 alpha expression. HIF-1 alpha-induced glucose metabolic reprogramming imparts 5-FU resistance in CRC. HIF-1 alpha is a potential biomarker for 5-FU-resistant CRC, and targeting HIF-1 alpha in combination with 5-FU may represent an effective therapeutic strategy in 5-FU-resistant CRC.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET

Wei-Chieh Huang et al.

Summary: The study reveals the oncogenic role of THEMIS2 in triple negative breast cancer (TNBC) and ovarian cancer stem cells (CSCs), and its mechanism involving the suppression of PTP1B association with MET. The overexpression of THEMIS2 is associated with chemoresistance and poor prognosis. Cryptotanshinone (CPT) can effectively inhibit cancer stemness by suppressing THEMIS2 expression, suggesting its potential clinical application as a treatment for THEMIS2 positive TNBC.

ONCOGENE (2022)

Add to Collection

Article Cell Biology

Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis

Feifei Li et al.

Summary: The study confirmed the anti-cancer effect of AHI on breast cancer through network pharmacology, MTT experiments, and RNA sequencing. AHI was found to inhibit BC cell growth by upregulating GPX1 expression, potentially exerting its anti-BC role by suppressing malignant epithelial-mesenchymal transition.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Selenium ameliorates mercuric chloride-induced brain damage through activating BDNF/TrKB/PI3K/AKT and inhibiting NF-κB signaling pathways

Lan-Xin Li et al.

Summary: Sodium selenite alleviated HgCl2-induced brain damage by activating the BDNF/TrKB/PI3K/AKT signaling pathway and suppressing NF-kappa B pathway, reducing oxidative stress and neuronal dysfunction.

JOURNAL OF INORGANIC BIOCHEMISTRY (2022)

Add to Collection

Article Oncology

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response

Tristan Rupp et al.

Summary: This study demonstrated the anti-cancer effects of CTLA-4 or PD-1 blockade in mouse colon and triple negative breast cancer models, as well as the different impacts on tumor immune cell subset infiltration.

TRANSLATIONAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial

Ali Razaghi et al.

Summary: This study aimed to analyze the effects of selenite treatment on soluble PD-L1 levels. The results showed that selenite treatment did not significantly affect the PD-1/PD-L1 axis, and there was no significant correlation between sPD-L1 expression and survival.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Role and Mechanism of Essential Selenoproteins for Homeostasis

Ruihua Ye et al.

Summary: Selenium is an essential trace element that plays a vital biological role in the body through selenoproteins. Selenoproteins are involved in various biological processes such as oxidative stress regulation, immune response, and antioxidant defense. Both deficiency and excess selenium can cause damage to the body. Selenium intake is mainly through dietary supplements. This paper reviews the synthesis and mechanism of selenoproteins, as well as their role and mechanism in disease regulation, and prospects the future development of selenium-enriched products.

ANTIOXIDANTS (2022)

Add to Collection

Article Reproductive Biology

Protective mechanism of selenium on mercuric chloride-induced testis injury in chicken via p38 MAPK/ATF2/iNOS signaling pathway

Xue-Wei Chen et al.

Summary: Selenium effectively alleviates HgCl2-induced testicular injury in chickens by enhancing antioxidant capacity and reducing inflammation.

THERIOGENOLOGY (2022)

Add to Collection

Article Nutrition & Dietetics

Selenium Yeast and Fish Oil Combination Diminishes Cancer Stem Cell Traits and Reverses Cisplatin Resistance in A549 Sphere Cells

I-Chun Lai et al.

Summary: The combination of selenium yeast and fish oil synergistically induces apoptosis in cancer stem cell-like cells and reverses drug resistance.

NUTRIENTS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers

Briana K. Shimada et al.

Summary: Selenium plays a crucial role in promoting the survival of cancer cells, particularly through resistance to ferroptosis. Cancer cells utilize selenium metabolism and selenoprotein action to resist oxidative damage and cell death mechanisms, highlighting the importance of selenium in cancer therapeutics.

BIOMOLECULES (2022)

Add to Collection

Article Oncology

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan

Anna R. Schreiber et al.

Summary: Sacituzumab govitecan has demonstrated promising survival benefits in patients with previously treated mTNBC based on data from the ASCENT trial. Common adverse effects include neutropenia, diarrhea, and nausea, which are manageable with supportive care. In addition to TNBC, Sacituzumab govitecan has shown potential in cancers such as urothelial and lung, and is being studied in HR-positive breast cancers. The therapy is likely to be used in combination with other novel targeted agents as ongoing clinical trials progress.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

Add to Collection

Article Health Care Sciences & Services

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls

Sara Bravaccini et al.

Summary: TROP-2 is an ideal candidate for targeted therapeutics, but its approval and adoption are facing delays in Italy. Universal guidelines and the standardization of TROP-2 evaluation are urgently needed to streamline the approval process and adoption of new drugs.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Oncology

Blocking Wnt/β-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas

Hui Zhang et al.

Summary: Blocking the Wnt/beta-catenin signal can enhance the efficacy of PD-1 blockade therapy on glioblastoma by inhibiting tumor proliferation and migration, as well as promoting T-cell infiltration and PD-L1 expression.

MOLECULAR CANCER THERAPEUTICS (2021)

Add to Collection

Article Medicine, General & Internal

A Pan-Cancer Analysis of the Role of Selenoprotein P mRNA in Tumorigenesis

Yanni Yang et al.

Summary: This study investigated the multifaceted properties of SELENOP in various cancers, including tissue-specific expression, prognostic value, immune function, and signaling pathway enrichment. SELENOP expression was associated with better prognosis in most cancers, but with poorer prognosis in LGG and UCEC. Furthermore, SELENOP showed correlation with infiltration level of six immune cell types.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer

Supriya Bevinakoppamath et al.

Summary: Obesity is a significant risk factor for various cancers, including breast cancer, due to the increased levels of inflammatory cytokines driving pro-proliferative pathways. The association of obesity with breast cancer is mainly attributed to elevated estrogen levels and oxidative stress caused by chronic low-grade inflammation.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Oncology

Selenium stimulates the antitumour immunity: Insights to future research

Ali Razaghi et al.

Summary: Selenium is a crucial trace element for regulating immune functions and plays important roles in cancer. At nutritional low doses, selenium acts as an antioxidant, while at supra-nutritional high doses, selenium induces redox signaling and cell death.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1

Joohyun Woo et al.

Summary: The study investigated the effect of selenium on HER2-positive breast cancer cells in response to trastuzumab, showing that the combination of selenium and trastuzumab had an antitumor effect in trastuzumab-resistant breast cancer cells by downregulating phosphorylated Akt and beclin1-related autophagy.

PLOS ONE (2021)

Add to Collection

Article Oncology

Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment

Xia Sun et al.

Summary: This study investigated the relationship between Trop2 and gefitinib resistance in NSCLC, revealing that Trop2 induces resistance through specific mechanisms. Silencing of Trop2 in combination with an IGF1R inhibitor significantly decreased NSCLC cell proliferation and reshaped the tumor microenvironment.

JOURNAL OF CANCER (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells

Yuhui Liu et al.

Summary: Rhein, a component of Chinese herb rhubarb, has been shown to inhibit pancreatic cancer cell growth by inducing apoptosis and arresting the cell cycle. When combined with oxaliplatin, Rhein synergistically enhances apoptosis in pancreatic cancer cells through increased ROS levels and inactivation of the PI3K/AKT pathway, suggesting it may be an effective strategy to overcome drug resistance.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Engineering, Environmental

HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy

Xiaojuan Zhang et al.

CHEMICAL ENGINEERING JOURNAL (2020)

Add to Collection

Article Oncology

Expression and prognostic potential of GPX1 in human cancers based on data mining

Rucliong Wei et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer

Francesca Capone et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Oncology

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Antonio Marra et al.

NPJ BREAST CANCER (2020)

Add to Collection

Article Oncology

Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis

Ziqi Peng et al.

JOURNAL OF CANCER (2020)

Add to Collection

Article Multidisciplinary Sciences

Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly

Pia Giovannelli et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Cell Biology

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge

Milica Nedeljkovic et al.

CELLS (2019)

Add to Collection

Review Oncology

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

L. Gerratana et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells

Martin Bertz et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Add to Collection

Article Cell Biology

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma

Nathan Redlich et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Article

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development*

Yousef Zakharia et al.

Oncotarget (2018)

Add to Collection

Article Oncology

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

Deepika Nair et al.

FRONTIERS IN ONCOLOGY (2018)

Add to Collection

Article Oncology

Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment

Alison E. Obr et al.

BREAST CANCER RESEARCH (2018)

Add to Collection

Article Oncology

TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT

Xinxing Li et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways

Hongyu Guan et al.

BMC CANCER (2017)

Add to Collection

Review Oncology

Biological Subtypes of Triple-Negative Breast Cancer

Michael Hubalek et al.

BREAST CARE (2017)

Add to Collection

Article Oncology

v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1

Xiaoming Ju et al.

CANCER RESEARCH (2016)

Add to Collection

Article Oncology

Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer

Nadine Tung et al.

NPJ BREAST CANCER (2016)

Add to Collection

Article Medicine, General & Internal

Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells

Chih-Hung Guo et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice

Chih-Hung Guo et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)

Add to Collection

Review Biochemistry & Molecular Biology

The role of the insulin-like growth factor-1 system in breast cancer

Panagiotis F. Christopoulos et al.

MOLECULAR CANCER (2015)

Add to Collection

Article Oncology

Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling

Maria D. Cuenca-Lopez et al.

BMC CANCER (2014)

Add to Collection

Article Multidisciplinary Sciences

N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor

Harri M. Itkonen et al.

PLOS ONE (2013)

Add to Collection

Review Nutrition & Dietetics

Selenium Metabolism in Cancer Cells: The Combined Application of XAS and XFM Techniques to the Problem of Selenium Speciation in Biological Systems

Claire M. Weekley et al.

NUTRIENTS (2013)

Add to Collection

Article Oncology

Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition

Sreenivasulu Chintala et al.

BMC CANCER (2012)

Add to Collection

Article Oncology

Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy

Zoe Davison et al.

NEOPLASIA (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion

Huawei Zeng et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)

Add to Collection

Article Oncology

Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action

Bryan Husbeck et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Add to Collection

Article Oncology

Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer

JY Chun et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Add to Collection

Article Oncology

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells

G Pandini et al.

CANCER RESEARCH (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.